Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
TC BioPharm Ltd (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TCBP
Nasdaq
8731
https://tcbiopharm.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for TC BioPharm Ltd (ADR)
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
- May 6th, 2024 5:01 pm
TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
- May 6th, 2024 12:30 pm
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
- Apr 4th, 2024 12:30 pm
TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
- Apr 2nd, 2024 12:30 pm
TCBP Adjourns General Meeting Until a Later Date
- Mar 19th, 2024 12:30 pm
TCBP Announces Exercise of Series D Warrants For Cash
- Mar 18th, 2024 12:30 pm
Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"
- Mar 1st, 2024 1:30 pm
/C O R R E C T I O N -- TC BioPharm/
- Feb 27th, 2024 10:15 pm
TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial
- Feb 22nd, 2024 2:32 pm
TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe
- Feb 15th, 2024 1:30 pm
TCBP Provides Shareholder Update and Highlights Upcoming Milestones
- Feb 14th, 2024 1:30 pm
TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'
- Jan 29th, 2024 1:30 pm
TC BioPharm to Present at the Sequire Investor Summit
- Jan 18th, 2024 1:30 pm
TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jan 4th, 2024 1:30 pm
TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies
- Jan 3rd, 2024 1:30 pm
TC BioPharm Announces Closing of $3.5 Million Public Offering
- Dec 22nd, 2023 1:30 pm
TC BioPharm Announces Pricing of $3.5 Million Public Offering
- Dec 19th, 2023 1:00 pm
TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D
- Dec 18th, 2023 4:15 pm
TC BioPharm Announces Plan to Implement ADS Ratio Change
- Dec 13th, 2023 11:30 am
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug
- Nov 28th, 2023 4:05 pm
Scroll